Mesoblast Ltd ADR (MESO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MESO | AMGN | GILD | CELG | VRTX |
| Company | Mesoblast Ltd ADR | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 4.95 | 265.64 | 67.01 | 108.01 | 394.19 |
| High | 5.20 | 265.92 | 67.02 | 108.59 | 396.14 |
| Low | 4.77 | 262.58 | 65.90 | 107.27 | 391.01 |
| Last | 5.11 | 262.75 | 66.16 | 108.24 | 393.48 |
| Change | +0.10 | -1.32 | -0.77 | +0.11 | +0.38 |
| % Change | +2.00% | -0.50% | -1.15% | +0.10% | +0.10% |
| Volume | 269,100 | 2,082,700 | 6,442,200 | 191,230,496 | 949,000 |
| 20-Day Average Volume | 5,928,530 | 2,201,900 | 6,214,910 | 16,188,930 | 909,480 |
| Previous Close | 5.01 | 264.07 | 66.93 | 108.13 | 393.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.94 | 272.96 | 70.21 | 108.17 | 406.59 |
| 20-Day Raw Stochastic | 57.63% | 0.65% | 3.10% | 63.25% | 8.11% |
| 20-Day Relative Strength | 59.91% | 36.64% | 27.91% | 64.69% | 36.90% |
| Weighted Alpha | -8.24 | +4.25 | -25.27 | +46.30 | +15.62 |
| Today's Opinion | 72% Buy | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 72% Buy | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 8% Sell | 8% Sell | 88% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.82% since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -1.97% since 11/13/19 | -1.69% since 04/11/24 |
| Low | 4.60 on 04/17/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 5.76 on 04/12/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 110.53 on 11/14/19 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | +121.21% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | +5.14% since 10/18/19 | -4.35% since 03/18/24 |
| Low | 2.05 on 03/22/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 7.36 on 04/01/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +197.09% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | +13.63% since 08/20/19 | -9.12% since 01/18/24 |
| Low | 1.72 on 01/23/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 7.36 on 04/01/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +118.38% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | +14.14% since 05/20/19 | +7.05% since 10/18/23 |
| Low | 1.61 on 01/18/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 7.36 on 04/01/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 571,496 | 141,520,144 | 83,333,008 | 77,035,920 | 101,600,240 |
| Shares Outstanding, K | 114,071 | 535,919 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 7,500,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -81,890,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 1,930,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -21,920,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 3.60 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 08/30/23 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/23/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 10.02 | 10.99 | 29.33 |